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A microwave-promoted and base-catalyzed synthesis of cycl[3.2.2]azines is accomplished in water via a
three-component reaction (3-CR) of 2-picoline, a-bromoacetophenone and alkyne. The extension of the
methodology to the synthesis of steroidal and carbocyclic cycl[3.2.2]azine is also reported.
 2010 Elsevier Ltd. All rights reserved.The indolizine ring system is an important structural motif fre-
quently found in natural products and has been used as an impor-
tant skeleton in pharmaceutics because of their interesting and
promising biological properties.1 Synthetic indolizines have found
wide-spread application in drug design efforts, biological, and
pharmaceutical research.2 Several reports are available showing
the potential of indolizine derivatives as histamine H3 receptor
antagonists,3 antimicrobacterial agents,4 leucotriene synthesis
inhibitors,5 calcium entry blockers,6 and inhibitors of 15-lipooxy-
genase.7 The synthesis of indolizine derivatives has been actively
investigated and many synthetic strategies for producing indoli-
zine derivatives have been described in the literature.8 Perhaps
the most widely utilized method is the Tschitschibabin indolizine
synthesis, in which a quaternary pyridinium halide, resulting from
the reaction of a 2-alkyl pyridine and an a-halo carbonyl com-
pound undergoes an intramolecular condensation to the indolizine
product.9 However, in many cases, expensive and toxic metals, ex-
tended reaction times, elevated thermal conditions, and environ-
mentally hazardous organic solvents are used.
The application of water as a solvent for performing organic
transformations under thermal and microwave heating has re-
ceived signiﬁcant interest as a green alternative.10 Water offers
practical advantages over organic solvents as it is readily available,
cheap, non-ﬂammable, and environmentally friendly. In addition,
the utility of unconventional microwave irradiation has been
increasingly recognized in organic synthesis in recent years. Micro-
wave-mediated multi-component reactions (MCRs) constitute a
particularly attractive synthetic strategy for rapid and efﬁcient li-
brary generation, enhanced reaction rates, cleaner products, and
manipulative simplicity. The interest in this area is evidenced by
the large number of papers and reviews, which appeared in the lit-
erature in the past few years.11–13ll rights reserved.
h).The cycl[3.2.2.]azine systems, which are tricyclic aromatic het-
erocycles having nitrogen as the central atom common to the three
rings, have attracted lots of attention due to their interesting phys-
ical and chemical properties.14 The most general method for the
synthesis of cycl[3.2.2]azine derivative is the (8 + 2)p cycloaddition
reaction of indolizines with acetylenes such as DMAD.15 However,
one of the discrepancies of this methodology is that it requires
costly and toxic metal catalysts (such as Pd on charcoal) as dehy-
drogenating agents in organic solvents.16 Hitherto, no report is
available for the synthesis of these cycl[3.2.2]azines using a mul-
ti-component reaction and water as the reaction media. Recently,
we have reported the synthesis of benzo[g]indoles from a-substi-
tuted acetophenone and naphthoquinone in the presence of urea
under microwave irradiation.17 In continuation of our interests,
herein we report an efﬁcient and facile base-catalyzed preparation
of cycl[3.2.2]azines via a three-component reaction between an al-
kyl pyridine, an a-bromo carbonyl compound, and an alkyne in
water. Our synthetic approach, which involves the cycloaddition
of in situ generated Tschitschibabin indolizine in aqueous media,
turned out to be the ﬁrst example of a metal-free preparation of
cycl[3.2.2]azines.
Typical reaction conditions for the preparation of the cy-
cl[3.2.2]azine system involve the treatment of alkylpyridines
(1a–c, 0.5 mmol) with a-bromo carbonyl compounds (2a–f,
1.2 equiv) and alkynes (3a–b, 1.5 equiv) in the presence of a base
in a round bottomed ﬂask open to air (Scheme 1). The product 2-
phenyl-4,5-dicarbmethoxy-cycl[3.2.2]azine (4a) was conﬁrmed
by spectroscopic and analytical techniques.18 The effect of solvents
on the rate and yield of the reaction was evaluated using 1a, 2a,
and 3a as model substrates in the presence of K2CO3 and the results
are summarized in Table 1. Different aprotic solvents, such as,
CH2Cl2, DMF, DMSO, toluene, and CH3CN and protic solvents, such
as MeOH, EtOH, and H2O were examined. It was observed that
protic solvents were signiﬁcantly preferred over aprotic solvents
and that the reaction in water was the fastest.
N Me
+
O
Br + N
1a , R1 = H 3a, R3 = R4 = COOMe
3b, R3 =H; R4 =COOEt
4a-k
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2a, R2 = Ph
2b, R2 = 4-Me-C6H4
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2d, R2 = 4-NO2-C6H4
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R3
R4
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Scheme 1.
Table 1
Effect of solvents on the formation of 4aa
N
+
O
Br
+ DMAD N
COOMeMeOOC1a 2a 3a 4a
Base
Thermal
Solvent % Yieldb
1 h 2 h 8 h 24 h
CH2Cl2 0 0 0 0
DMF 0 5 8 8
DMSO 0 0 0 0
Toluene 0 0 0 0
CH3CN 2 4 4 8
MeOH 10 20 25 35
EtOH 8 15 26 40
H2O 70 78 84 80
a Reactions were carried out at 100 C using 0.5 mmol of 2-picoline (1a) with
phenacylbromide (2a, 1.2 equiv), DMAD (3a, 1.5 equiv) and K2CO3 (1.5 mmol).
b Yields are based on HPLC analysis compared to an analytical sample.
Table 2
Synthesis of cycl[3.2.2]azines 4a–k in aqueous mediuma
Entry Alkylpyridine Acylbromide Alkyn
1 N Me
1a
O
Br
2a DMAD
2 1a O
Br
Me
2b 3a
3 1a O
Br
Cl
2c 3a
4 1a O
Br
O2N 2d 3a
5 1a 2a Ethyl
6
N Me
Me
1b 2a 3b
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medium under microwave irradiation using various 2-alkyl pyri-
dines, acyl bromides, and alkynes with modiﬁcation at the pyridyl
ring, aromatic moiety of acetophenone and alkyne substituents
(Table 2). Hence, substrates with alkylpyridines (1a–c), substituted
acetophenones (2a–d) and alkynes (3a–b) afforded cycl[3.2.2]a-
zine products (4a–i) within 2–5 min in 20–92% yield.18,19 It was
observed that substrates bearing an electron releasing group at
the para position of the aromatic ring (2b) facilitated the enhance-
ment in yields of the products (entries 2 and 6), whereas electron
deﬁcient 2d gave lower yields (entries 4 and 8). The three-compo-
nent reactions (3-CRs) in water were found sluggish when carried
out under thermal conditions (1–24 h) in comparison to micro-
wave heating wherein the reactions were very rapid (2–5 min).
In the light of the operational simplicity and mild condition of
our cycl[3.2.2]azine synthesis, we intended to expand the de-
scribed protocol to the preparation of steroidal and non-steroidal
derivatives. Reaction of 1a with 21-bromo-pregn-5,16-dieno-3-
acetate (2e) and 3a under identical conditions afforded 4j in 78%
yield (Table 2, entry 10). Similarly a-bromoacetyl-1-cyclohexenee Productb Yieldc
3a
N
COOMeMeOOC
4a
90
N
COOMeMeOOC
Me
4b 92
N
COOMeMeOOC
Cl
4c
60
N
COOMeMeOOC
NO2
4d
20
propiolate 3b
N
COOEt
4e 78
N
COOEt
Me
4f
80
Table 2 (continued)
Entry Alkylpyridine Acylbromide Alkyne Productb Yieldc
7 1b 2b 3b N
Me
COOEt
Me
4g
74
8
1c
N Me
Me
2c 3b N
COOEt
Cl
Me
4h
65
9 1c 2d 3b N
COOEt
NO2
Me
4i
22
10 1a
AcO
O
Br
2e
3a
4j
OAc
N
COOMeMeOOC
78
11 1a
2f
O
Br
3a
N
MeOOC COOMe
4k 74
a Conditions: 1 (1 mmol), 2 (1.2 mmol), 3 (1.5 mmol), K2CO3 (1.5 mmol), water (10 ml).
b Reactions were carried out under microwave irradiation for 2–5 min at 100 C.
c Isolated yields.
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entry 11).
A plausible mechanism is proposed for the formation of 4a from
the water mediated three-component reaction (Scheme 2). The
quaternary salt (A), obtained from the reaction of 2-picoline (1a)
with a-bromoacetophenone (2a) initially undergoes cyclodehydra-
tion in the presence of base to afford the Tschitschibabin indolizine
(B), which then undergoes [3 + 2]cycloaddition with DMAD (3a) to
form dihydrocycl[3.2.2]azine (C). Finally, the oxidation of the latter
to 4a is rapidly accomplished under microwave irradiation in the
presence of air to form the stable 10p aromatic system. As a sup-
port of this hypothesis, we carried the reaction sequentially in or-
der to isolate the various intermediates. Hence, 2-picoline (1a) and
phenacyl bromide (2a) were ﬁrst reacted under basic condition to
afford Tschitschibabin indolizine (B).20 The latter was then sub-
jected to DMAD (3a) in water under microwave irradiation to rap-
idly trigger the cycloaddition and the concomitant aerial oxidationBaseN
O
Ph
Me+
Br
_
N
Ph
DMAD
N
Ph
COOMeMeOOC
H H
N
Ph
COOMeMeOOC
Aerial oxidation
1a + 2a
(A)
(B)
(3a)
4a (C)
Scheme 2.to afford 4a in good yield (88%).21 It was interesting to note that the
three-component reaction in water required no metal catalyst for
the oxidation of C to stable aromatic 4a in contrast to reactions
carried in organic solvents. All of our efforts to isolate dihydro-
cycl[3.2.2]azine (C) when performing the three-component reac-
tion under anaerobic condition failed as it solely led to 4a.
Moreover, the metal-free two-component reaction of B with 3a
in reﬂuxing toluene failed in our hands.16a,16b
In conclusion, we have developed an efﬁcient and fast reaction
for the synthesis of cycl[3.2.2]azines using water as a reaction
medium under microwave irradiation. The reaction proceeds via
the initial formation of the corresponding Tschitschibabin indoli-
zine, followed by a [3 + 2]cycloaddition with an alkyne with con-
comitant aerial oxidation. We have further shown that this
reaction can be applied to the synthesis of cycl[3.2.2]azine starting
from steroidal and carbocyclic acyl bromides. Our procedure in
aqueous medium is environmental friendly and devoid of organic
solvents and metal catalysts.
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